OrSense Ltd.'s Non-Invasive Continuous Glucose Monitoring System Demonstrates Excellent Results In Home Use Setting

NES ZIONA, Israel--(BUSINESS WIRE)--Sept. 14, 2006--Results of a study by a group of clinicians at the Chaim Sheba Medical Center and Tel Aviv University, presented at the 42nd Annual Meeting of the European Association for the Study of Diabetes taking place September 14-17, 2006 in Copenhagen-Malmo, indicate that NBM-100G, a non-invasive continuous glucose monitoring system developed by OrSense Ltd., accurately measures levels of glucose in a home-like setting.